| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |